| Dr Virgilio D Corpuz, MD | |
|
915 13th Ave N, Clinton, IA 52732-5067 | |
| (563) 243-2511 | |
| (563) 243-0817 |
| Full Name | Dr Virgilio D Corpuz |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 915 13th Ave N, Clinton, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831148774 | NPI | - | NPPES |
| 0075135 | Medicaid | IA | |
| 018399 | Other | HEALTH ALLIANCE | |
| 20310 | Other | IA | WELLMARK BC/BS |
| IA0138 | Other | JOHN DEERE HEALTH | |
| 27193 | Other | IOWA HEALTH SOLUTIONS | |
| 18984 | Other | MIDLANDS CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 28261 (Iowa) | Primary |
| Entity Name | Mercy Specialty Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386832764 PECOS PAC ID: 3375639586 Enrollment ID: O20071019000139 |
News Archive
Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance.
The skin can be damaged in many different ways – some are environmental, such as sun exposure, while others are the result of conditions such as acne or melasma. While this damage affects only small areas of the skin, past skin rejuvenation procedures treated large areas of the skin whether it was damaged or not.
The New York Times, in a series of ongoing stories about health care delivery in other countries, interviewed John Creighton Campbell, of the University of Michigan and visiting researcher at the Tokyo University Institute of Gerontology who has studied Japan's health care system.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Virgilio D Corpuz, MD 915 13th Ave N, Clinton, IA 52732-5067 Ph: (563) 243-2511 | Dr Virgilio D Corpuz, MD 915 13th Ave N, Clinton, IA 52732-5067 Ph: (563) 243-2511 |
News Archive
Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance.
The skin can be damaged in many different ways – some are environmental, such as sun exposure, while others are the result of conditions such as acne or melasma. While this damage affects only small areas of the skin, past skin rejuvenation procedures treated large areas of the skin whether it was damaged or not.
The New York Times, in a series of ongoing stories about health care delivery in other countries, interviewed John Creighton Campbell, of the University of Michigan and visiting researcher at the Tokyo University Institute of Gerontology who has studied Japan's health care system.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 1 days ago